0,1,2,3,4,5
"Table 3
continued",,,,,
Drug class members,"Activity against other viruses
Activity against",Clinical status,,Known safety issues,Comments
,coronavirusesa,,,,
Clomipramine,"MERS-CoV:
EBOV [100]","Approved for
treatment of depression",Well,tolerated,WHO list of essential medicines
hydrochloride,9.3 lM [38];,,,,
,SARS-CoV:,,,,
,13.2 lM [38],,,,
Fluphenazine,"MERS-CoV:
HCV [149]; EBOV [100]","Approved for
treatment of chronic",Well,tolerated,WHO list of essential medicines;
hydrochloride,5.9 lM [38];,psychoses,,,CAD
,SARS-CoV:,,,,
,21.4 lM [38],,,,
Fluspirilene,MERS-CoV:,"Approved for
treatment of",Well,tolerated,
,7.5 lM [38],schizophrenia,,,
,SARS-CoV:,,,,
,5.9 lM [38],,,,
Promethazine,MERS-CoV:,Antipsychotic approved for sedation,Well,tolerated,
hydrochloride,11.8 lM [38],,,,
,SARS-CoV:,,,,
,7.5 lM [38],,,,
Thiothixene,MERS-CoV:,Antipsychotic approved for treatment of,Well,tolerated,
,9.3 lM [38],schizophrenia,,,
,SARS-CoV:,,,,
,5.3 lM [38],,,,
Triethylperazine,"MERS-CoV:
SFV [45], CHIKV [45, 99]",Approved antiemetic,Well,tolerated,
maleate,7.8 lM [38],,,,
Triï¬‚upromazine,MERS-CoV:,Approved antipsychotic,,Serious side effects,CAD
hydrochloride,5.8 lM [38];,,,include akathisia.,
,SARS-CoV:,,,,
,6.4 lM [38],,,,
Nucleic acid synthesis inhibitors,,,,,
Gemcitabine,"MERS-CoV:
In vitro:","Approved for
treatment of cancers",Well,tolerated,WHO list of essential medicines
hydrochloride,1.2 lM [38],,,,
,FLUAV [125],,,,
,In vivo:,,,,
,Mice MuLV [124],,,,
Mizoribine,"SARS-CoV: 3.5-
HCV [123]; BVDV [280]",Approved immunosuppressant,"in organ
Well",tolerated,
,16 lg/mL [114],transplantation and rheumatic,,,
,or[40 lM,diseases.,,,
,[111],,,,
Mycophenolic acid,"MERS-CoV:
DENV [118]; CHIKV [252]; FLUAV",Approved immunosuppressant,"in organ
FDA alert:",risk of,
,"0.17 lg/mL
[112]; SFV, SINV [45]",transplantation,,"activation of
latent",
